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ABSTRACT
Aim of study. We investigated the effectiveness and safety of an antegrade approach consisting of emergency ICA stenting in 
conjunction with mechanical thrombectomy (MT) in a one-stage procedure as a treatment for Tandem Occlusion (TO).
Clinical rationale for study. We here describe our experience in the treatment of TO with an antegrade approach with long-
-term results. We also discuss the advantages and drawbacks of this treatment modality with special attention to possible 
haemorrhagic complications that can be encountered in patients with ischaemic stroke who receive antiplatelet treatment. We 
believe that our study adds to the limited number of reports on this topic. 
Materials and methods. We selected 34 patients diagnosed with acute ischaemic stroke due to ICA and ipsilateral intracranial 
occlusion treated with ICA stenting in conjunction with MT.
We analysed the short- and long-term results as well as investigating complications with special regard to haemorrhagic trans-
formation associated with the need for antiplatelet treatment after stent implantation in patients after acute ischaemic stroke 
treatment.
Results. A favourable angiographic outcome was defined as mTICI 2b–3. This was achieved in 33/34 patients (97%). On average, 
NIHSS at 24 hours after the procedure was 8.5 ± 7, which indicates a significant clinical improvement. Four cases of symptomatic 
ICH were observed (11.8%). One re-occlusion in stent was noted. At three-month follow-up, mRS scores were 0 in 11 (34.3%), 1 in 
5 (16%), 2 in 1 (3%), 3 in 3 (9.3%), 4 in 3 (9.3%), and 5 in 2 (6%) patients. Seven patients did not survive (22%). Overall, a favourable 
outcome (mRS 0–2) was achieved in 17/34 patients (50%). The final mortality rate was 26.5% (9/34 patients).
Conclusions and clinical implications. We conclude that an antegrade approach is a feasible and effective method for treating 
acute TO stroke, giving the patient the chance to regain his or her full independence in everyday life, with low overall compli-
cation and final mortality rates.   
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Introduction
A tandem occlusion (TO) is defined as the simultaneo-
us high-grade stenosis or occlusion of the internal carotid 
artery in its extracranial segment plus the occlusion of the 
ipsilateral intracranial vessel. It is estimated that TO accounts 
for about 20% of all acute strokes [1]. TO and its treatment 
appear to be underrepresented in the literature [2]. Con-
servative treatment of tandem occlusions with intravenous 
thrombolysis (IVT) alone is associated with poor clinical 
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outcomes. Therefore several operative strategies have been 
developed [3]. 
 A two-stage treatment comprising mechanical throm-
bectomy (MT) and stenting of the extracranial carotid artery 
lesion in different sessions is reported to cause fewer hae-
morrhagic complications compared to carotid artery stenting 
in conjunction with intracranial MT in a one-stage treatment 
[4]. One-stage treatment poses questions regarding the appro-
ach, i.e. antegrade with primary recanalisation of the ICA 
with subsequent MT, or retrograde where the MT is followed 
by the ICA recanalisation [5]. Finally, there is the retriever 
wire supported carotid artery revascularisation (REWISED 
CARE) technique, which treats both vessels simultaneously 
[6]. Nonetheless, there is currently no standard approach to 
the treatment of acute tandem occlusion stroke.
The aim of this study was to assess the efficacy and safety 
of ICA stenting followed by mechanical thrombectomy as an 
approach for urgent treatment of tandem occlusions. 
Clinical rationale for study
In this manuscript, we describe our experience in the 
treatment of TO with an antegrade approach, including our 
long-term results. We discuss the advantages and drawbacks 
of this treatment modality, paying special attention to the 
possible haemorrhagic complications that can be encounte-
red in patients with ischaemic stroke who receive antiplatelet 
treatment. We believe that this study is a valuable addition to 
the limited number of reports on this topic. 
Materials and methods
Materials
This was a prospective, single-centre study of the data of 
34 patients (10 female, 24 male) diagnosed between January 
2016 and May 2019 with acute ischaemic stroke due to TO. All 
patients were diagnosed by non-contrast computer tomograp-
hy and CT-angio. This disclosed extracranial ICA occlusion of 
atherosclerotic aetiology and a concomitant MCA occlusion. 
Baseline demographics, medical history and comorbidities 
were collected from the patients. Neurological status was as-
sessed at baseline using the National Institute of Health Stroke 
Scale (NIHSS). This study was approved by our institutional 
review board (IRB) – approval number KE-0254/285/2019.
Statistical analysis of obtained data using Statistica 
13.5 (StatSoft Polska, Poland) was performed. Student’s t-
-test was used to analyse data with normal distribution, and 
a Mann–Whitney U test was applied to data without normal 
distribution. Logistic regression analyses were carried out to 
determine the predictors of 90-day mortality. 
Inclusion criteria 
The inclusion criteria were tandem occlusion and lack 
of intracerebral haemorrhage (ICH) confirmed in imaging 
examination. Assessment of ICH was performed according to 
the guidelines for the management of spontaneous intracere-
bral haemorrhage issued by the American Heart Association/
American Stroke Association [7]. Patients presenting within 
4.5 hours from symptoms onset were eligible for intraveno-
us therapy, in accordance with the guidelines of the Polish 
Neurological Society for the Management of Patients with 
Ischaemic Stroke [8]. These patients were additionally tre-
ated with intravenous tissue plasminogen activator (iv-tPA) 
(0.9 mg/kg) before undergoing mechanical thrombectomy. 
Mechanical thrombectomy was performed within a six-hour 
therapeutic window. Control cranial computed tomography 
was performed 4–6 hours and again 24 hours after treatment, 
and in case of ICH further scans were acquired every 48 hours. 
Symptomatic ICH was defined as any parenchymal haematoma 
or intracranial haemorrhage associated with worsening of the 
National Institutes of Health Stroke Scale (NIHSS) score by 
4 or more points. 
Exclusion criteria
Patients with any contraindications for either thrombolytic 
or thrombectomic therapy, according to the guidelines of the 
Polish Neurological Society for the Management of Patients 
with Ischaemic Stroke [8], or time from symptoms of more 
than four and half hours in the case of thrombolytic, and more 
than six hours in the case of thrombectomic, therapy, were 
classified as ineligible. Patients with a National Institutes of 
Health Stroke Scale score  < 6 at baseline, or with evidence of 
intracranial haemorrhage on admission, or with a modified 
Rankin Scale Score > 2 prior to stroke onset and with dissection 
of ICA were also excluded from the study. 
Methods
All ICA occlusions were treated by balloon angioplasty 
followed by stenting, and all distal occlusions with mechanical 
thrombectomy (MT). Data concerning additional IV tissue 
plasminogen treatment, arrival and treatment times, duration 
of procedure, as well as technical aspects, was collected.
Endovascular procedure 
All interventions were performed under general anaes-
thesia. Firstly, an 8F guide catheter was advanced distally to 
the common carotid artery (CCA). Then, a protection device 
(FilterWire, Boston Scientific, Natick, MA, USA) was placed 
in the petrous segment of the ICA. The occlusion was passed 
with a 0.014-inch microwire, and then a micro-catheter was 
advanced past the occlusion. Angiography assessing ICA and 
occlusion status was performed. Open-cell stent (Acculink, 
Abbott Vascular, Temecula, CA, USA) was deployed along 
the stenosis and post-dilated with a balloon.
Mechanical thrombectomy with an aspiration device 
(Penumbra System; Penumbra, Alameda, CA, USA) was per-
formed once the adequate patency of ICA had been obtained. 
During the procedure 2,500 units of heparin was administered. 
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The reperfusion was assessed by an interventional neurora-
diologist after the procedure, based on the modified Treatment 
in Cerebral Infarction (mTICI) Scale. Successful recanalisation 
was defined as a persistent mTICI 2b–3 score.
Antiplatelet treatment
Following the endovascular procedure, all patients recei-
ved antiplatelet treatment: aspirin (75 mg daily for at least six 
months) after admission to the Stroke Unit (up to 30 minutes 
after the procedure). Where there was no evidence of ICH 
in control CT 4–6 hours after the treatment, clopidogrel was 
administered (75 mg daily for at least three months). Where 
ICH occurred, this secondary antiplatelet drug was omitted. 
Secondary stroke prevention
All patients with atrial fibrillation on admission received 
additional VKA therapy or NOAC according to the Guideli-
nes for the Prevention of Stroke in Patients with Stroke and 
Transient Ischaemic Attack [9].
Follow-up 
A follow-up evaluation was conducted within three 
months of the procedure. This included clinical and neurolo-
gical examinations (NIHSS was assessed 12 hours, 24 hours, 
and seven days after mechanical thrombectomy as well as 
at discharge from the hospital). The Modified Rankin Scale 
(mRS) score at 90 days was evaluated by a trained physician 
and was based either on a clinical investigation or a structured 
telephone interview. All patients underwent imaging examina-
tions during hospitalisation: two control head CTs (4–6 hours 
and 24 hours after the intervention) and at least two Transcra-
nial Doppler (TCD) ultrasound examinations (24 hours after 
procedure and at discharge). In cases of clinical deterioration, 
additional imaging examinations were performed. 
Safety outcomes included periprocedural complications, 
adverse events occurring during the follow-up period, and 
overall mortality at three months.
Results
During the study period, 34 patients underwent MT due 
to TO. The demographic details of the study population are 
set out in Table 1. 
In total, 10 female and 24 male patients were included. 
Mean age was 70.6 years. Mean baseline NIHSS was 16.4 ± 5.4. 
Most common risk factors were: hypertension (97%) and hy-
perlipidemia (47%). Smoking was reported by 35% of patients. 
Baseline medications included: antihypertensive drugs (97%), 
statins (35%), antiplatelet drugs (21%), and NOAC (15%). 
Intracranial occlusion sites were the right and left carotid 
artery in 59% and 41% respectively. Horizontal segment of the 
MCA (M1) was occluded in 76.5% and Sylvian (M2) segment 
in 23.5% of the analysed patients. Mean Onset-to-Reperfusion 
time was 223 ± 60 min (Tab. 2). Twenty-three patients (67.6%) 
Table 1. Demographic aspects of study population
Patients (n) 34 
10 female (29%),  
24 male (71%)
Mean age (years) (min – max)
Mean NIHSS (min – max)
Mean blood pressure
Blood glucose (min – max)
70.6 (49 to 81)
16.4 (7 to 23)
152/85
136 (93 to 262)
Risk factors:
    Hypertension
    Atrial fibrillation
    Hyperlipidemia
    Diabetes mellitus
    Smoking 
    Cardiovascular disease
History of stroke/TIA:
    < 3 months
Medication:
    Antihypertensive drug
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Table 2. Mean time elapsed from symptom onset
Time Minutes (min – max)
Onset — arrival
Onset — needle
Onset — reperfusion 
Groin — reperfusion
86 (20 to 240)
115 (50 to 270)
223 (110 to 340)
55 (30 to 120)
with a mean Onset-to-Needle time of 115 mins were eligible 
for IVT.
A favourable angiographic outcome, defined as mTICI 
2b–3, was achieved in 33 out of 34 patients (97%). No emboli 
to previously unaffected territories occurred. On average, 
NIHSS at 24 hours after the procedure was 8.5 ± 7, which 
indicates a significant clinical improvement. Mean hospitali-
sation time was 16 days (from 6 to 41 days). In one case (3%), 
haematoma at the site of the arterial puncture occurred, but 
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Figure 2. Statistically significant O–A differences between groups 
of patients who survived and who died
Figure 1. Statistically significant age differences between groups 
of patients who survived and who died
it did not require surgical intervention. During this period, 
four cases of symptomatic ICH were observed (11.8%). Two of 
these patients died during hospitalisation. Thirty-two patients 
were thus further followed-up. Carotid revascularisation was 
monitored using Transcranial Doppler (TCD) ultrasound exa-
mination. Re-occlusion was observed in one patient. Regarding 
follow-up at three months, mRS scores were 0 in 11 (34.3%), 
1 in 5 (16%), 2 in 1 (3%), 3 in 3 (9.3%), 4 in 3 (9.3%), and 5 in 
2 (6%) patients. Seven patients did not survive (22%). Overall 
a favourable outcome (mRS 0–2) was achieved in 17 of the 
original 34 patients (50%). The final mortality rate was 26.5% 
(9/34). No secondary acute ischaemic incidence was observed. 
All four patients with haemorrhagic transformation of the 
stroke had hypertension and two (50%) admitted smoking 
before their stroke. Other comorbidities included hyperlipi-
demia (50%) and diabetes mellitus (50%). As far as baseline 
medication was concerned, all of them reported the use of 
antihypertensive drugs and half of them the use of statins. 
Nevertheless, statistical analysis did not show any significant 
correlation between risk factors and haemorrhagic transfor-
mation of the stroke. 
Interestingly, a statistically significant negative correlation 
between the patient’s age and mortality was observed (p < 0.05) 
(Fig. 1). The second independent factor (p < 0.05) significantly 
affecting final mortality was Onset-to-Arrival time (Fig. 2, Tab. 
3). Figure 3A–B presents the linear regression of statistically 
significant factors. 
Comparing the two groups (favourable vs unfavourable 
90-days mRs) showed a statistically significant (p value 
= 0.018) correlation between baseline NOAC use and long-
-term outcome. None of the patients with a favourable 90-
days mRs score reported NOAC use before admission, while 
5/17 (29%) patients with unfavourable mRs score did. Baseline 
NIHSS and time from onset to arrival were important factors 
determining a favourable outcome (Tab. 4). 
Discussion
Mechanical thrombectomy (MT) has become an estab-
lished treatment modality for patients with intracranial lesions 
of anterior circulation. However, the optimal approach to the 
proximal lesion of the Internal Carotid Artery in Tandem 
Occlusions remains a matter of debate. 
In this study, we demonstrated the safety, technical aspects 
and clinical outcome of ICA stenting in conjunction with MT 
as a treatment for patients with TO in a comprehensive manner 
by prospectively enrolling 34 patients. 
Our main conclusion was that it seems to be an effective 
and safe approach, even in patients treated with Intravenous 
Thrombolysis prior to the procedure. Our findings accord with 
those of a meta-analysis including nearly 600 patients [10]. Our 
favourable outcome at 90 days, defined as mRs < 2, in 50% of 
patients is comparable with the results of other studies [2]. 
The need for dual antiplatelet agents in the acute phase 
of a stroke due to stent implantation raises questions con-
cerning haemorrhagic complications after tandem occlusion 
endovascular treatment. The results of the most recent meta-
-analysis comparing two groups of patients treated due to TO 
(the first received no antiplatelet and the second received at 
least one antiplatelet agent during the procedure) show that 
although the rate of favourable outcome was comparable in 
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Table 3. Comparison of all factors taken into consideration in analysing death and survival of patients; test used — T-student, b — Mann-Whitney U test, 
*statistically significant difference
Outcome
Survived Died p Used test
27; 100% 7; 100%
Age, years (ME ± SD) 72.2 ± 8.1 64.3 ± 8.1 0.027* a
Gender (male n, %) 18; 67% 6; 85.71% 0.345 b
NIHSS 15.4 ± 5.6 19.9 ± 2.6 0.052 a
Hypertension (n, %) 26; 96% 7; 100% 0.662 b
Atrial fibrillation (n, %) 7; 26% 2; 29% 0.911 b
TIA/stroke (n, %) 5; 19% 0; 0% 0.238 b
Smoking (n, %) 11; 41% 1; 14% 0.208 b
Dyslipidemia 13; 48% 3; 43% 0.825 b
Diabetes mellitus (n, %) 9; 33% 3; 43% 0.662 b
Antiplatelet drugs (n, %) 5; 19% 3; 43% 0.192 b
NOAC (n, %) 3; 11% 2; 29% 0.267 b
Statins (n, %) 12; 44% 2; 29% 0.469 b
Hypotensive drugs (n, %) 26; 96% 7; 100% 0.469 b
O-A min (ME ± SD) 78.2 ± 51.8 125 ± 34.5 0.01* b
O-N min (ME ± SD) 111.2 ± 54.7 138.3 ± 20.2 0.411 a
O-G min (ME ± SD) 159.8 ± 58.4 198.7 ± 41.4 0.11 a
O-R min (ME ± SD) 214.6 ± 60.6 255 ± 48 0.115 a
Time of procedure min (ME ± SD) 73.3 ± 38.8 60 ± 23.8 0.415 b
Figure 3. A–B: Logistic regressions of factors determining survival at 90 days. A. Logistic regression of age and survival of patients. 
B. Logistic regression of O–A of patients
Death
Survival
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both groups, both a higher successful reperfusion rate and 
a lower 90-day mortality rate were observed in the second 
group [11]. And this was without increasing the risk of any 
intracerebral haemorrhage. Symptomatic ICH was observed 
in 9.8% of patients without any antiplatelet, and in 7.3% of 
patients with ≥ 1 antiplatelet drug. 
Antiplatelet treatment after carotid stenting depends 
on the particular centre’s experience. The most common 
combinations include aspirin, clopidogrel and antiGP2b3. 
Some authors have reported lowering of the intraoperative 
thromboembolic complication rate after intraoperative ad-
ministration of eptyfibatyd during emergent endovascular 
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Table 4. Comparison of all factors taken into consideration in analysing favourable and unfavourable outcomes in mRS after 90 days; test used a — T-stu-
dent, b — Mann-Whitney U test, *statistically significant difference
Outcome
Positive Negative p Used test
17; 100% 17; 100%
Age years (ME ± SD) 69.4 ± 7.7 71.8 ± 9.4 0.409 a
Gender (male n, %) 11; 65% 13; 76% 0.47 b
NIHSS 13.5 ± 5 19.2 ± 4.2 < 0.001* a
Hypertension (n, %) 17; 100% 16; 94% 0.35 b
Atrial fibrillation (n, %) 3; 18% 6; 35% 0.26 b
TIA/stroke (n, %) 2; 12% 3; 18% 0.653 b
Smoking (n, %) 6; 35% 6; 35% 1 b
Dyslipidemia (n, %) 6; 35% 10; 59% 0.182 b
Diabetes mellitus (n, %) 4; 24% 8; 47% 0.163 b
Antiplatelet drugs (n, %) 4; 24% 4; 24% 1 b
NOAC (n, %) 0; 0% 5; 29% 0.018* b
Statins (n, %) 5; 29% 9; 53% 0.18 b
Hypotensive drugs (n, %) 17; 100% 16; 94% 0.35 b
O-A min (ME ± SD) 63.8 ± 53.1 110.9 ± 40.1 0.007* b
O-N min (ME ± SD) 100.2 ± 60.2 133.5 ± 33 0.131 a
O-G min (ME ± SD) 149.7 ± 58.6 185.4 ± 51 0.071 a
O-R min (ME ± SD) 204.7 ± 55.8 240.6 ± 59.9 0.085 a
Time of procedure min (ME ± SD) 76.8 ± 41.2 64.4 ± 30.7 0.425 b
neurointerventions [12]. They also observed no increase of 
haemorrhagic complications. Nonetheless, no standard treat-
ment protocol has been developed to date. In our hospital, all 
patients were treated with dual antiplatelet therapy consisting 
of aspirin and clopidogrel, a treatment regime of which we 
have more than 20 years of experience. 
In our study, symptomatic ICH was observed in four 
patients (11.8%). All of them received IVT, which in conjun-
ction with antiplatelet therapy is a known factor elevating the 
risk of intracranial haemorrhage [13–14]. Diabetes mellitus, 
which was described as an impactful factor of haemorrhagic 
transformation by the authors of the TITAN Review Colla-
boration Study, was noted in 2/4 patients [15]. Of these, two 
had an mRs score of 4 and the other two patients had died at 
90-day follow-up, resulting in mortality of 50%. 
The rate of haemorrhagic complications after endovascular 
treatment of Tandem Occlusion seems comparable with the 
rate of haemorrhagic complications after isolated intracra-
nial MT, as presented by the authors of major studies [16]. 
Nevertheless, several authors have described the benefits of 
a conservative approach consisting of internal carotid angio-
plasty or its delayed treatment and mechanical thrombectomy. 
The most comparable study, with a nearly identical number 
of cases comparing two groups of patients (with and without 
acute stenting of cervical lesion), reports similar rates of 
favourable outcomes in both groups [17]. The authors attri-
buted the favourable outcome to the following factors: prein-
terventional ASPECT score and successful recanalisation of 
the intracranial occlusion. No positive impact of ICA stenting 
in regard to 90-days mRs score was observed in a multi-centre 
study on nearly 400 patients [18]. 
However, the authors of both of the abovementioned 
studies noted a significantly higher rate of successful reca-
nalisation of the intracranial vessel after treating the carotid 
lesion either by PTA or by PTA and stenting during the acute 
phase of the stroke. One should bear in mind that successful 
recanalisation is crucial for clinical success. 
As far as the technical aspects of the procedure are concer-
ned, there are several options to treat tandem occlusion. Some 
authors claim the retrograde approach treating intracranial 
occlusion firstly to be superior due to the shorter Onset-to-
-Reperfusion time compared to an antegrade approach [19]. 
Lockau et al. reported significantly shorter times in a ‘throm-
bectomy-first’ group compared to a ‘stent-first’ group [20]. 
In our series, the median Groin-to-Reperfusion time of 55.4 
± 23.7 minutes was comparable with the results achieved in 
the ‘thrombectomy-first’ group (58.6 ± 26.1).
 Navigation through an occluded vessel is an old technique. 
Modern guiding wires and microcatheters enable passage in 
most cases [21]. However, there is always a risk of a thrombus 
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dislodgement, especially while advancing thrombectomy 
systems. 
On the other hand, several cases of spontaneous reper-
fusion of the intracranial occlusion has been described in 
patients with tandem occlusions after stenting of the pro-
ximal ICA. This may indicate the benefits of an antegrade 
approach [22]. 
Another issue that has prompted ongoing debate is the 
optimal anaesthetic approach during endovascular therapy. 
General anaesthesia may be associated with less pain and 
movement during the procedure, which facilitates the endo-
vascular manoeuvres. Additional intubation lowers the risk of 
aspiration [23]. Conscious sedation, on the other hand, may 
be associated with less time from onset to reperfusion and 
a lower ventilation‐associated‐complications risk. Many syste-
matic reviews and observational studies have reported worse 
outcomes from general anaesthesia compared to conscious 
sedation during endovascular therapy for acute ischaemic 
stroke [24–26]. 
However, one should bear in mind that patients with 
more serious stroke and worse outcome prognosis are much 
more likely to be treated under general anaesthesia. A re-
cent meta‐analysis of randomised clinical trials indicated 
that general anaesthesia during MT results in significantly 
higher rates of functional independence than does conscio-
us sedation [27]. In our centre, the choice of anaesthetic 
approach strongly depends on the clinical condition of 
the patient. Our patients with tandem occlusions typically 
presented with severe neurological deficits (mean baseline 
NIHSS 16.4 ± 5.4), and were therefore treated under general 
anesthesia. 
The increased use of novel oral anticoagulants (NOACs) 
to control atrial fibrillation and its effectiveness in preventing 
ischaemic stroke and lowering the risk of haemorrhages is 
another interesting matter. In our study, the use of NOAC was 
a statistically significant factor among patients with an unfavo-
urable outcome. Shpak et al. compared over 130,000 patients 
divided into two groups (one on NOACs and one on warfarin) 
and concluded that there was a significantly higher frequency 
of ischaemic strokes in the NOAC group [28]. The frequency 
was higher regardless of the NOAC used, but the highest in-
cidence was observed with dabigatran and apixaban. Embolic 
events might be explained by poor treatment adherence and 
subtherapeutic dosages of drugs [29]. 
Our case series demonstrates the endovascular treatment 
of Tandem Occlusion consisting of ICA stenting in conjunction 
with mechanical thrombectomy. The strengths of this report 
include its prospective character, the comprehensive manner 
of data collection, and the analysis of short- and long-term 
outcomes. We are, however, aware of several limitations. 
Firstly, a small sample size limits the generalisability of the 
findings. Secondly, our statistical analysis might be imprecise 
because the study included relatively few patients. 
Clinical implications 
In conclusion, the described antegrade approach is a fea-
sible and effective method for the treatment of patients with 
acute ischaemic stroke due to Tandem Occlusion. It gives them 
the chance to regain full independence in everyday life, and 
overall complication and final mortality rates are low. Addi-
tionally, dual antiplatelet therapy after the procedure does not 
significantly increase the risk of haemorrhagic transformation 
of the stroke. 
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